TRANSPARENCY COUNCIL MEETING NO. 44/2023 NOVEMBER 6, 2023
1. tezspire (tezepelumab) Indication: under drug program B.44. Treatment of patients with severe asthma (ICD-10: J45, J82) Decision problem: preparing a position paper on the evaluation of the drug
2. "Health policy program for the residents of the Municipality of Slawno in the field of medical rehabilitation for 2023-2027" Decision-making problem: preparation of an opinion on the draft health policy program of the local government unit
3. "Health policy program on prevention and early detection of lifestyle diseases in children and adolescents "6-10-14 for Health" for 2024-2026". Decision-making problem: preparing an opinion on the draft health policy program of a local government unit
4. "Subsidy for infertility treatment by in vitro fertilization for residents of the City of Przemyśl for 2024-2026". Decision-making problem: prepara...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
